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Abstract
Introduction: Equol is a metabolite of soy isoflavon called daidzein which is produced by gastrointestinal 
tract bacteria. This research aims to analyze the maturation of vaginal epithelium and dyspareunia symptoms in 
producing and non-producing equol menopausal women.
Methods: This is a cross sectional research. Subject was a community of menopausal women who fulfilled 
inclusion criteria. Subjects were asked to sign a written informed consent. Subjects underwent vaginal epithelium 
maturation assessment and were asked whether she experienced dyspareunia. Research was conducted in January 
2017.
Results: There was a significant difference on the maturation of vaginal epithelium and dyspareunia symptoms 
between equol producing and non-producing women (p < 0.05). This research found that in equol producing 
menopausal women, there was a shift-to-the-right vaginal epithelium maturation with more superficial cells 
compared to parabasal cells produced and less dyspareunia. Meanwhile, in women who did not produce equol, 
there was a shift-to-the-left vaginal epithelium maturation with more parabasal cells compared to superficial cells 
produced and more dyspareunia.
Conclusion: In equol producing menopausal women, vaginal epithelium will undergo a shift-to-the-right 
maturation, with more superficial cells produced compared to women who did not produce equol.
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Maturasi Epitel Vagina dan Gejala Dispareunia pada Wanita Menopause 
yang Menghasilkan Equol dan Wanita yang Tidak Menghasilkan Equol
Abstrak
Pendahuluan: Equol adalah metabolit isoflavon kedelai yang disebut daidzein yang diproduksi oleh bakteri 
saluran pencernaan. Penelitian ini bertujuan untuk menganalisis maturasi epitel vagina dan gejala dispareunia 
pada wanita menopause yang memproduksi dan tidak memproduksi equol.
Metode: Penelitian ini merupakan penelitian cross sectional. Subjek penelitian adalah sekelompok wanita 
menopause yang memenuhi kriteria inklusi. Subjek diminta untuk menandatangani persetujuan tertulis dan 
menjalani penilaian maturasi epitel vagina dan ditanya apakah mengalami dispareunia. Penelitian dilakukan pada 
Januari 2017.
Hasil: Terdapat perbedaan yang signifikan pada maturasi epitel vagina dan gejala dispareunia antara wanita yang 
memproduksi equol dan yang tidak memproduksi (p <0,05). Pada wanita menopause yang memproduksi equol, 
terjadi pematangan epitel vagina shift-to-the-right disertai produksi sel superfisial yang lebih banyak dibandingkan 
sel parabasal dan lebih sedikit gejala dispareunia. Sementara itu, pada wanita yang tidak menghasilkan equol, 
terjadi pergeseran shift-to-the-left maturasi epitel vagina dengan produksi sel parabasal lebih banyak dibandingkan 
sel superfisial dan lebih sering gejala dispareunia.
Kesimpulan: Wanita menopause yang memproduksi equol mengalami maturasi epitel vagina shift-to-the-
right disertai produksi sel superfisial yang lebih banyak dibandingkan dengan wanita menopause yang tidak 
memproduksi equol.
Kata kunci: dyspareunia; equol; maturasi epitel vagina
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Introduction
Menopause is defined as permanent cessation 
of menstruation. According to the World 
Health Organization (WHO), menopause 
is defined as the time point of permanent 
menstrual cessation due to loss of ovarian 
function. Life expectancy in Indonesia in 2012 
is about 69 years old, thus every Indonesian 
woman will experience menopause. The age 
of female menopause in developed countries 
such as the United States and Britain is 51.4 
years, while in Southeast Asian countries 
it is 51.09 years. The age of menopause 
for Indonesian women is 50 years. Upon 
entering the menopause, associated with 
decreased estrogen levels, women have an 
increased risk of chronic abnormalities in the 
long term, such as coronary heart disease, 
osteoporosis, decreased cognitive function 
and malignancy.1-3
     In menopausal women there will be an 
anatomical and physiological changes from 
the vagina, associated directly with reduced 
estrogen levels. Anatomic changes include 
reduced collagen, hyalinization, elastin 
deficiency, epithelial depletion, altered 
smooth muscle cell function, increased 
connective tissue density, and less blood 
vessels. Physiological changes result in 
reduced vaginal blood flow, vaginal discharge, 
flexibility, elasticity of the vaginal dome, and 
increased vaginal pH. In addition, decreased 
vaginal tissue strength and increased fragility 
of the vaginal tissues may predispose to 
vaginal epithelial damage so that during 
sexual activity vaginal penetration, causing 
vaginal pain, burning, irritation, and bleeding 
after sexual intercourse.4  
Equol is a metabolite of soy isoflavones 
called daidzein produced by bacterial 
gastrointestinal tract and not every human 
being is able to produce equol. Equol is not 
derived from plants, but is specially produced 
by bacteria that convert daidzein into the 
metabolite. The similarity of the structure also 
contributes to the prevention of symptoms 
that occur in menopausal women. Equol is 
the active metabolite of daidzein  which is 
secreted through urine.5-7
Not everyone has intestinal microflora 
that can turn daidzein into equol. Based on 
previous research, it was known that only 30 
- 60% of human beings were able to produce 
equol from daidzein; thus, the terminology 
“equol producer” and “non equol producer” 
were created.8, 9
Significant evidence has been found 
regarding equol: equol can reduce complaints 
related to menopause. Recent research 
has been conducted on a group of post-
menopausal women in Bandung in 2014. This 
study is a demographic survey to determine 
equator producers and not equator producers 
and their association with menopausal 
symptoms. The study intended to show 
that only female equator producers benefit 
from equol. This study was conducted with 
the knowledge of the presence of equol in 
women urine post menopause and knowing 
of postmenopausal symptoms through a 
questionnaire of Menopause Rating Scale 
(MRS). Postmenopausal women selected 
in this study were women who had similar 
characteristics, aged 40-60 years, had a 
homogeneous daily diet, had menopause 
between 1-5 years, and not being on hormone 
therapy. The result of the study was that there 
was a significant positive correlation between 
postmenopausal women’s urine equol levels 
with menopausal symptoms that arise and the 
quality of life.5, 10, 11
In this study, the pap smear examination 
results will be examined in correspondence 
to the index of vaginal epithelial maturation. 
The Maturation Index (MI) is a tool that 
can to evaluate female hormones. MI can 
be collected from the vagina, conjunctiva, 
urethra, and buccal mucosal surfaces. The 
index is read left to right and refers to percent 
and parabolic, intermediate, and superficial 
squamous cells appearing in a smear, with 
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total and all three values equal to 100%. 
A leftward shift indicates an increase in 
parabasal or intermediate cells in menopausal 
women, when a rightward shift indicates an 
increase in superficial cells or intermediates 
at the age of reproduction. Dyspareunia 
complaints in postmenopausal women with 
right shift of dyspareunia complaints will be 
less than in menopausal women with a shift 
to the left.12
Methode
This research was an observational study 
with cross sectional approach to analyze 
vaginal epithelial maturation and dyspareunia 
symptoms on equol producing and non equol 
producing phenotypes. This research activity 
was conducted at Outpatient Installation of Dr. 
Hasan Sadikin General Hospital, Bandung; 
Posbindu Teratai group of Cimindi Raya 
Hill Complex, Pasirkaliki; and Posyandu and 
Posbindu groups of Cileunyi and Anatomy 
Pathology Laboratory of Faculty of Medicine 
Universitas Padjadjaran. The study was 
conducted from January 2017.
     The subjects of the study was community 
of menopausal women consisting equol 
producers and non equol producers, who had 
done equol assessment in previous studies, 
who were healthy and met the inclusion 
criteria, were not included in the exclusion 
criteria and were willing to participate in the 
study by signing written informed consent 
until the minimum sample size of RSHS 
employees and Posyandu group of Cimindi-
Pasirkaliki and Cileunyi areas was fulfilled. 
The inclusion criteria in this study were 
healthy menopausal women who were willing 
to follow the study. Meanwhile, the exclusion 
criteria in this study were menopausal women 
who underwent hormonal treatment. The 
total number of minimum samples calculated 
using the formula for testing the difference of 
two population proportions was 52 patients.
The independent variables in this 
research were equol producing and non 
equol producer. Meanwhile, the dependent 
variables in this study were vaginal epithelial 
maturation, shift-to-the-right and shift-to-
the-left, as well as dyspareunia symptoms. 
Descriptive analysis was used to determine 
the characteristics of research subjects who 
become the sample research. Numerical data 
such as patient age and BMI were presented 
as mean, standard deviation, median and 
range. The samples’ characteristic data 
considered as categorical data such as gender 
and the patient’s occupation were coded 
and presented as frequency distribution and 
percentage.
Prior to statistical tests, numerical 
data were tested for the normality of data 
distribution using the Sapiro-Wilk test if 
the data were less than 50, or alternatively 
Kolmogorov-Smirnov test if the data were 
more than 50. The significance test for 
comparing the characteristics of the two study 
groups used the paired t-test if the data was 
normally distributed and the Mann-Whitney 
test as an alternative if the data was not 
normally distributed. Meanwhile, statistical 
analysis for categorical data was using the 
Chi-square test if Chi-Square requirements 
were met, or the Exact Fisher test as an 
alternative for 2 x 2 table and Kolmogorov 
Smirnov for table size other than 2 x 2. The 
criterion of significance used was p-value, 
p-score	 ≤	 0,05	 was	 considered	 significant	
or significant statistically, while p-score > 
0,05 was not considered significant or not 
statistically significant. The data obtained is 
recorded in a special form and then processed 
through SPSS version 21.0 for Windows.
Results
This study was conducted for 1 month, 
January 2017. During this period, there were 
52 subjects who met the inclusion criteria 
and excluded the exclusion criteria. Research 
subjects were healthy menopausal women 
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including RSHS employees, members of 
the Posbindu group of Cileunyi region, and 
members of the Jatinangor Posbindu group 
who were willing to take anamnesis about the 
symptoms of dyspareunia, and urine equol 
examination that had been done in previous 
research.
Table 1 described the age ratio of the 
equol producer group and the non equol 
producer. Mean age of the equol producers 
group was 51.73 ± 3.945, while the average 
age of the non equol producer was 55.69 ± 
3.283. BMI of the equol producers group 
averaged at 26.44 ± 4.130, while the non 
equol producers averaged at 25.43 ± 8,580
     These numerical data was tested using 
paired T-test if the data were distributed 
normally and Mann Whitney test alternative 
if the data was not normally distributed; as 
in age and BMI. The result of statistic test 
in the age group above obtained that the 
P-score of age was smaller than 0.05 (P value 
< 0.05) which meant that it was significant 
or statistically significant. Meanwhile, the 
result of the P-score of BMI was greater 
than 0.05 (P value > 0.05), which meant 
that it was not significant or not statistically. 
Thus, it could be concluded that there is no 
statistically significant difference between 
the BMI of equol producer and non equol 
producer group.
Based on analysis results for age, all P 
values were less than 0,05 (p <0,05), hence 
it could be concluded from both group that 
there were differences in characteristic at the 
beginning of examination. This showed both 
groups were not equal or not homogeneous. 
The result of BMI characteristic analysis, in 
which all P values were more than 0,05 (p> 
0,05), can conclude that both group were 
equal or that there was no difference of 
characteristic at the beginning of examination. 
This indicated that both groups are equal or 
homogeneous, which meant it was feasible 
to compare and test for further statistical 
hypotheses.
Table 2 illustrated the proportion of 
dyspareunia in the groups of equol producers 
and non equol producers. In this study, the 
p-score for dyspareunia was < 0.05, indicating 
that the variable was significant or statistically 
significant; thus it can be concluded that 
there was a statistically significant difference 
between the dyspareunia in equol producer 
and non equol producers groups. The 
analysis of categorical data in the above table 
was tested by using Mann-Whitney statistics 
test, in which the information obtained a 
P-value of 0.0001, which was smaller than 
0.05 (p value <0.05), and meant that it was 
Table 1  Characteristics of research subjects
Variables
Group
P-scoreEquol Producer Non Equol Producer
N = 26 N = 26
Age 0.000**
Mean ± STD 51.73 ± 3.945 55.69 ± 3.283
Median 51.000 55.5000
Range (min-max) 47.00-60.00 50.00-65.00
BMI 0.592
Mean ± STD 26.44 ± 4.130 25.43 ± 8.580
Median 25.400 23.500
Range (min-max) 19.20-34.20 19.10-65.04
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significant or statistically significant. Thus, it 
can be explained that there was a statistically 
significant or statistically significant 
difference between the dyspareunia variables 
in the two study groups, ie the equol producer 
and non-equol producer group.
Table 3 describes the comparison of 
epithelial maturation in the equol-producing 
group and the non equol producing group. 
In this study, the epithelial maturation 
had a p value < 0.05, so, it was significant 
or statistically significant; thus it can be 
explained that there was a statistically 
significant difference between epithelial 
maturation variables for the equol producer 
group and non equol producer group. The 
analysis of categorical data in the above 
table was tested by using Mann-Whitney 
statistical test, where the P value was found 
to be 0.012, which was smaller than 0.05 
(p value < 0.05) which meant that it was 
significant or statistically significant. Thus, it 
can be explained that there was a statistically 
significant difference between epithelial 
maturation variables in the two study groups, 
ie. equol producer group and non-equol 
producer group.
Discussions
This research was a study to determine 
whether there was a difference in vaginal 
epithelial maturation and dyspareunia 
symptoms in post-menopausal women 
producing equol and non equol producing. In 
this study, subjects were healthy menopausal 
women who fulfilled the inclusion criteria, 
not included in the exclusion criteria and 
were willing to participate in the study by 
signing written informed consent forms until 
the number of samples fulfilled the minimum 
sample size. Samples included employees of 
RSHS as well as members of Posbindu Group 
at Cileunyi and Jatinangor. Total number of 
study subjects who met the inclusion criteria 
and excluded the exclusion criteria was 52 
women. The researchers performed history 
taking regarding the presence of dyspareunia 
symptoms and papsmear examination to 
assess vaginal epithelial maturation.
     Based on Table 1, the age of menopausal 
women averaged at 53.7 years with a 
Table 2  Comparison of dyspareunia experiences between equol producer and non equol 




No                    Yes
Equol producer 25 (96.2%) 1 (3.8%) 0.0001
Non equol producer 8 (30.8%) 18 (69.2%)
Table 3  Comparison of epithelial maturation in equol producer and non equol producer 




Equol producer 17 (65.4%) 9 (34.6%) 0.012
Non equol producer 8 (7.7%) 18 (69.2%)
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standard deviation of 4.1 years, with median 
age of 48 years. The youngest respondent 
was 47 years old and the oldest respondent 
was 65 years. Overall, it was shown that the 
average age of menopausal women having 
various menopausal symptoms was similar 
to those of previous studies, ie, around 49-51 
years of age. Average age of Asian women 
experiencing menopause was 51 years.
The BMI of menopausal women was in 
average 25.9, with standard deviation of 6.6, 
with median BMI of 24.1, lowest BMI was 
19 and highest BMI was 65. In this study, it 
was found that women producing equol had 
in average higher BMI than women who did 
not produce equol.
In the equol producing group, 25 or 96.2% 
of women were found to have no dyspareunia 
while 1 or 3.8% of women were found to be 
experiencing dyspareunia. Meanwhile, in 
the non-equol producing group, 8 or 30.8% 
of women did not experience dyspareunia 
and as many as 18 or 69.2% of women were 
found to be experiencing dyspareunia. Based 
on categorical data analysis with Chi-square, 
it was found that the P value for dyspareunia 
was less than 0.05 (p value < 0.05), which 
meant that it was significant or statistically 
significant. Thus it can be explained that there 
was a significant or statistically significant 
difference in the proportion of dyspareunia 
in the two study groups, ie equol producer 
group and non-equol producer group. 
The next purpose of this study as 
mentioned in the introductory section was 
to analyze the maturation of the vaginal 
epithelium and the symptoms of dyspareunia 
in post-menopausal women who produce 
and did not produce equol. Currently, in 
addition to pharmacologic drugs of estrogen 
preparations, phitoestrogen is also developed 
to reduce the symptoms in menopausal 
women. About 60-70% of Asian women 
and only 20-30% of women in Europe and 
America are equol producers. A diet rich 
in soya (isoflavones) is believed to have an 
effect on lower menopausal symptoms and 
higher levels of equol in women in Asia. This 
study distinguished between equol producers 
and non equol producers. It also assessed the 
differences in dyspareunia symptoms in post-
menopausal women who produce and did not 
produce equol.13-15
The vagina is an elastic fibromuscular 
tissue that connects the external genitalia 
with the internal genitalia and consists of 
a layer of basal cell of the cube, several 
layers of parabasal cells and several layers 
of thin intermediate cells (layered epithelial 
epithelium), whose thickness changes 
according to age. The change in thickness 
and maturation of this epithelium, as well 
as the content of glycogen in it are related to 
hormonal status. Estrogen activates mitosis 
and is associated with increased epithelial 
thickness and an increase in the amount of 
glycogen. After menopause, the epithelium 
becomes thin again. The vagina maintains 
its ecological balance in which hormones, 
hormone-sensitive epithelium, hormone-
sensitive epithelium and various bacteria 
interact to maintain a healthy environment. 
In this ecosystem, estrogen plays a role 
in estrogen receptive cells to stimulate 
proliferation and maturation. In addition, 
the glycogen content of the squamous 
cells increases. This situation allows the 
development of Doderlin, Corynebacteria and 
other non-pathogenic bacteria. As a result, 
these organisms will metabolize glycogen 
to produce lactic acid, which will cause low 
pH to have an effect on the inhibition of the 
growth of pathogenic organisms.16
A decrease in the hormone estrogen 
causes the vaginal lining tissue to become 
thin and secretions or mucus in the vagina 
begin to decline so that when sex will arise 
pain. Vaginal atrophy occurs because vaginal 
secretion is reduced after menopause. In 
addition, the vaginal wall becomes thin and its 
elasticity is reduced and becomes shorter and 
lower, resulting in discomfort and pain during 
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sexual activity. Vaginal narrowing occurs 
3-6 months after menopause and symptoms 
are felt within 5 years of menopause. The 
vulvovaginitis atrophy is a common condition 
in menopausal women and has a considerable 
impact on the quality of life of women. The 
condition of hypoestrogen causes vaginal 
atrophy and vulvar vestibulum. The tissue 
becomes thinner, easily irritated and also 
more prone to secondary infection. Usually 
women complain of heat sensation in the 
vulva, dysuria, pruritus, dyspareunia and 
pain. A watery discharge may occur and is 
not uncommon for fissures in the vagina. 
This disorder can usually be diagnosed by 
a physical examination, although cytology 
should be confirmed for confirmation and 
diagnosis. Vaginal epithelium becomes 
thinner, pale, rugae decreases. At first the 
capillary blood vessels will appear like 
reddish spots that will then appear to be 
more rare and the vagina looks more slick 
and shiny. For more objective examination, 
a smear examination is taken from the upper 
third of the vagina on the lateral side to see 
the maturity index.17
Since estrogen stimulates the maturity 
of the vaginal epithelial cells from the basal 
stratum to the upper layer cells, generally in 
postmenopausal women smear examination 
will show a decrease in the number of 
superficial cells to the absence of any such 
cells. The presence of basal cells in a dominant 
number with the absence of superficial cells 
indicates the occurrence of atrophy.18
Dyspareunia is a pain in the genitalia 
region that arises during or after sexual 
intercourse without the presence of 
vaginismus. This repetitive pain will 
cause less stress, anxiety and interpersonal 
relationships, which in turn will result in 
a woman’s avoidance of sex. Dyspareunia 
affects almost 2/3 women during their 
lifetime. Dyspareunia is one of the most 
common symptoms and atrophic vaginitis 
that has not been treated well.
The Maturation Index (MI) is a tool that is 
able to evaluate hormones that affect women. 
The index is read left to right and refers to 
percentage as well as the number of parabolic, 
intermediate, and superficial squamous cells 
appearing in a smear, with total and all three 
values  equal to 100%. For example, an MI 
0/40/60 represents 0% parabasal cells, 40% 
intermediates, 60% superficial. A leftward 
shift indicates an increase in parabasal 
or intermediate cells, when a shift to the 
right indicates an increase in superficial or 
intermediate cells. Between post-menopausal 
women, equol-producing women experienced 
less dyspareunia symptoms than non equol 
producing women.12
In this study, dyspareunia is less common 
in post-menopausal equol producing women 
because dyspareunia is a result of lack of 
estrogen in menopausal women. In post-
menopausal women who produced equol, 
due to equol as a derivates, the maturation 
of the vaginal epithelium will be better than 
in menopausal women who did not produce 
equol. Therefore, in the equol producer group, 
there were more superficial cells, resulting a 
shift-to-the-right.
In post-menopausal women, the vaginal 
epithelium becomes thin, pale and the rugae 
diminishes. At first the capillary blood 
vessels will appear like reddish spots that 
will then appear to be more rare and the 
vagina looks more slick and shiny. So that 
in menopausal women who did not produce 
equol, dyspareunia occurred more frequently 
and vaginal epithelial maturation had a shift-
to-the-left, with more parabasal cells in the 
vaginal epithelium.
The limitation of this research was that it 
was a cross sectional study, so future research 
as a cohort is needed to further evaluate 
vaginal epithelial maturation and degree 
of dyspareunia in post-menopausal women 
producing equol and non equol producing. 
Further research can be developed to assess 
whether there is a degree of dyspareunia 
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relationship with equol levels. A previous 
study found that soy diet had an increased 
maturation effect from vaginal epithelium. 
Consuming soy may increase estrogen levels 
in menopausal women, resulting in increased 
vaginal epithelial maturation as well as 
increased maturation of vaginal epithelium 
and vaginal epithelial changes from parabasal 
cells into superficial cells using isoflavones 
gel. Therefore, postmenopausal women 
menopause may want to maintain a diet that 
contains isoflavones.19, 20
Conclusions
Based on research data and discussion, there 
were a few conclusions: (1) maturation 
of vaginal epithelium in equol producing 
menopausal women had a shift-to-the-right 
compared to women who did not produce 
equol, and (2) dyspareunia symptoms were 
experienced less often by equol producing 
menopausal women compared to women 
who did not produce equol.
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